The influence of oseltamivir treatment on the risk of stroke after influenza infection

Cardiology

Volumn 113, Issue 2, 2009, Pages 98-107

  Madjid, Mohammad ^a,b,c   Curkendall, Suellen ^d   Blumentals, William A ^e  

^a TEXAS HEART INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Cerner LifeSciences   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

Cardiovascular epidemiology; Cardiovascular risk factors; Influenza infection; Ischemic heart disease; Stroke

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; ESTROGEN; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; OSELTAMIVIR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTIVIRAL AGENTS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; RETROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR; STROKE;

EID: 56149109332     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172796     Document Type: Article

References (30)

1. Madjid M, Naghavi M, Litovsky S, Casscells SW: Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-2736.
2. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW: Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J 2004;31:4-13.
3. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE, Casscells SW 3rd: Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007;28:1205-1210.
4. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P: Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-2618.
5. Field TS, Zhu H, Tarrant M, Mitchell JR, Hill MD: Relationship between supra-annual trends in influenza rates and stroke occurrence. Neuroepidemiology 2004; 23:228-235.
6. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P: Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002;33:513-518.
7. Grau AJ, Fischer B, Barth C, Ling P, Lichy C, Buggle F: Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005;36: 1501-1506.
8. Madjid M, Awan I, Ali M, Frazier L, Casscells W: Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther 2005;5:91-96.
9. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM; American Heart Association; American College of Cardiology: Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 2006; 114:1549-1553.
10. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102:3039-3045.
11. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B: Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) study. Circulation 2002; 105: 2143-2147.
12. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-1332.
13. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-42.
14. Singleton JA, Wortley P, Lu PJ: Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J 2004;31:22-27.
15. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG: Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235.
16. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P: Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-1850.
17. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG: Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-1024.
18. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F: Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163:1667-1672.
19. Nordstrom BL, Sung I, Suter P, Szneke P: Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Curr Med Res Opin 2005; 21:761-768.
20. McGeer A: Oseltamivir was safe and effective for prophylaxis of influenza in the frail elderly. ACP J Club 2002; 136:24.
21. D'Agostino RB Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281.
22. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W: Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apo-lipoprotein E-deficient mice. Circulation 2003; 107:762-768.
23. Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernandez JA, Barndt R, Quismorio FP Jr, Weiner JM, Fisher M: Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 1996;27:2005-2011.
24. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM: High-density li-poprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation 2001; 103:2283-2288.
25. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE: Local and systemic cy-tokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-649.
26. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE: Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282:1240-1246.
27. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, Mc-Dermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171.
28. Gillum RF: Cerebrovascular disease morbidity in the United States, 1970-1983. Age, sex, region, and vascular surgery. Stroke 1986;17:656-661.
29. Madjid M, Casscells SW: Of birds and men: cardiologists' role in influenza pandemics. Lancet 2004;364:1309.
30. Madjid M, Luepker RV, Greenlund KJ, Taubert KA, Roy MJ, Robertson RM: ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs. J Am Coll Cardiol 2007;49:1407-1412.